CV Sciences, Inc. Announces Publication of Two Research Studies Demonstrating the Safety and Health Benefits of PlusCBD™ Products Jun 2, 2020
CV Sciences, Inc. Announces Plan to Adjourn Annual Meeting of Stockholders to June 16, 2020 May 20, 2020
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction May 20, 2020
CV Sciences, Inc. Receives Notice of Patent Allowance from USPTO for Proprietary Cannabidiol (CBD) and Nicotine Formulation for Treating Smokeless Tobacco Addiction Apr 6, 2020